Pharmaceutical Drug Delivery Market to Reach $2,307.27 Billion, Globally, by 2032 at 4.4% CAGR: Allied Market Research

The growth of the global pharmaceutical drug delivery market is driven by increase in number of people suffering from various chronic diseases such as cancer, cardiovascular diseases, and respiratory diseases, technological advancement in drug delivery system, and rise in demand for advanced drug delivery such as controlled-release formulation.

PORTLAND, Ore., July 5, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Pharmaceutical Drug Delivery Market, By Route of Administration (Oral Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Topical Drug Delivery, and Other Drug Delivery), By Application (Cancer, Diabetes, Cardiovascular Diseases, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global pharmaceutical drug delivery industry was estimated at $1,498.72 billion in 2022, and is anticipated to hit $2,307.27 billion by 2032, registering a CAGR of 4.4% from 2023 to 2032.

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/6467 

Prime determinants of growth

Increase in prevalence of chronic diseases due to changing lifestyle, increase in smoking population, and development of advanced drug delivery products drive the growth of the global pharmaceutical drug delivery market. However, strict government regulations for the approval of new pharmaceutical drug delivery products hampers the pharmaceutical drug delivery market growth. On the contrary, increase in demand for advanced drug delivery products is expected to offer remunerative opportunities for expansion of the pharmaceutical drug delivery market during the forecast period.

Report coverage & details:

Covid-19 Scenario

• The pharmaceutical drug delivery market growth was moderate during the lockdown period owning to, increase in demand for injectable delivery systems for vaccine administration, disruption in supply of pharmaceutical drugs, and delay in research projects.
• Furthermore, the demand for pharmaceutical drug delivery is increasing post pandemic due to rise in prevalence of chronic diseases, and development of advanced drug delivery products. This, in turn, presented various growth opportunities for companies operating in the pharmaceutical drug delivery market.

Procure Complete Report at 20% Discount (236 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/pharmaceutical-drug-delivery-market/purchase-options

The other drug delivery segment to maintain its leadership status throughout the forecast period

Based on route of administration, the other drug delivery segment held the largest market share in 2022, accounting for more than two-fifths of the global pharmaceutical drug delivery market revenue in 2022, owing to, increase in use of injectable drug delivery during the COVID-19 pandemic. However, oral drug delivery is expected to grow at highest CAGR of 4.9% during the forecast period owing to, increase in adoption of extended release oral drug delivery products.

The others segment to maintain its lead position during the forecast period

Based on application, the others segment accounted for the largest share in 2022, contributing to nearly half of the global pharmaceutical drug delivery market revenue and it is projected to maintain highest CAGR of 4.8% during the forecast period, owing to, increase in prevalence of respiratory diseases such as asthma and other neurological diseases.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/6467 

North America to maintain its dominance by 2032

Based on region, North America held the largest market share in terms of revenue in 2022, accounting for more than two-fifths of the global pharmaceutical drug delivery market revenue, owing to rise in adoption of advanced pharmaceutical drug delivery products, increase in prevalence of chronic diseases, and strong presence of market key players. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.1% from 2023 to 2032, owing to increase in adoption of advanced drug delivery products, and rise in healthcare expenditure.

Leading Market Players: -

• Bayer AG
• Cipla Ltd
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson and Johnson
• Merck and Co., Inc.
• Novartis AG
• Amgen Inc.
• Pfizer Inc.
• Sanofi

The report provides a detailed analysis of these key players of the global pharmaceutical drug delivery market. These players have adopted strategy such as, acquisition to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Trending Reports in Healthcare Industry

Medical Gas Analyzers Market Expected to Reach $325 Million by 2025

Antibiotics Market Expected to Reach $50,374 Million by 2025

Healthcare Chatbot Market Expected to Reach $116.9 Million by 2026

Pharmaceutical Filtration Market Expected to Reach $7.74 Billion by 2026

Drug Delivery Devices Market Expected to Reach $26.7 Billion by 2026

Artificial Cornea and Corneal Implant Market Expected to Reach $656.19 Million by 2028

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg 

SOURCE Allied Market Research